Evidence map›Paper›PMID 38632250›Full record

ArticleScientific reports2024

Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer.

Tahani Bakhsh, Safiah Alhazmi, Ali Farsi, Abdulaziz S Yusuf, Amani Alharthi, Safa H Qahl, Maha Ali Alghamdi, Faisal A Alzahrani, Ola H Elgaddar, Mohanad A Ibrahim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Tahani BakhshDepartment of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia. tabakhsh@uj.edu.sa.
Safiah AlhazmiDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Ali FarsiDepartment of Surgery, Faculty of Medicine, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Abdulaziz S YusufDepartment of Biochemistry, Faculty of science, Stem Cell Unit, King Fahad Center for Medical Research, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Amani AlharthiDepartment of Biology, College of Science Al-Zulfi, Majmaah University, 11952, Majmaah, Saudi Arabia.
Safa H QahlDepartment of Biology, College of Science, University of Jeddah, Jeddah, Saudi Arabia.
Maha Ali AlghamdiDepartment of Biotechnology, College of Science, Taif University, Taif, Saudi Arabia.
Faisal A AlzahraniDepartment of Biochemistry, Faculty of science, Stem Cell Unit, King Fahad Center for Medical Research, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Ola H ElgaddarDepartment of Chemical Pathology, Alexandria University, Alexandria, Egypt.
Mohanad A IbrahimData Science Program, King Abdullah International Medical Research Center, 11481, Riyadh, Saudi Arabia.
Ahmed BahieldinDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia. abmahmed@kau.edu.sa.
King Abdulaziz University · SAUniversity of Jeddah · SAAlexandria University · EGKing Abdullah International Medical Research Center · SAMajmaah University · SASoliman Fakeeh Hospital · SATaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most common cancer affecting people. The discovery of new, non-invasive, specific, and sensitive molecular biomarkers for CRC may assist in the diagnosis and support therapeutic decision making. Exosomal miRNAs have been demonstrated in carcinogenesis and CRC development, which makes these miRNAs strong biomarkers for CRC. Deep sequencing allows a robust high-throughput informatics investigation of the types and abundance of exosomal miRNAs. Thus, exosomal miRNAs can be efficiently examined as diagnostic biomarkers for disease screening. In the present study, a number of 660 mature miRNAs were detected in patients diagnosed with CRC at different stages. Of which, 29 miRNAs were differentially expressed in CRC patients compared with healthy controls. Twenty-nine miRNAs with high abundance levels were further selected for subsequent analysis. These miRNAs were either highly up-regulated (e.g., let-7a-5p, let-7c-5p, let-7f-5p, let-7d-3p, miR-423-5p, miR-3184-5p, and miR-584) or down-regulated (e.g., miR-30a-5p, miR-99-5p, miR-150-5p, miR-26-5p and miR-204-5p). These miRNAs influence critical genes in CRC, leading to either tumor growth or suppression. Most of the reported diagnostic exosomal miRNAs were shown to be circulating in blood serum. The latter is a novel miRNA that was found in exosomal profile of blood serum. Some of the predicted target genes of highly expressed miRNAs participate in several cancer pathways, including CRC pathway. These target genes include tumor suppressor genes, oncogenes and DNA repair genes. Main focus was given to multiple critical signaling cross-talking pathways including transforming growth factor β (TGFβ) signaling pathways that are directly linked to CRC. In conclusion, we recommend further analysis in order to experimentally confirm exact relationships between selected differentially expressed miRNAs and their predicted target genes and downstream functional consequences.

Indexed as

Colorectal NeoplasmsExosomesMicroRNAsBiomarkersHumansPrognosisSerumBiomarkersMicroRNAsMIRN204 microRNA, humanBiomarkersColorectal cancerDeep sequencingExosomesmiRNAs

Identifiers

PMID38632250
PMCPMC11024162
OpenAlexW4394872440

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.